Cisplatin vs. carboplatin in routine treatment of advanced non-small cell lung cancer – results from the prospective German TLK cohort study. 15. Januar 2018 von Verschuer, U., Schnell, R., Zahn, M.-O., Eggert, J., Binninger, A., Spring, L., Jänicke, M., Marschner, N., 2017. Oncol Res Treat 40 (suppl 3)(P600), 174. Treatment reality and outcome data of patients with advanced papillary cell carcinoma – data from the German prospective RCC-Registry. Staehler, M., Goebell, P., Müller, L., Overkamp, F., Frank, M., Kruggel, L., Jänicke, M., Marschner, N., 2017. Oncol Res Treat 40 (suppl 3)(P339), 96. Weiterlesen Clinical Research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP): a prospective German Registry in stage IV NSCLC AIO-TRK-0315). Griesinger, F., Eberhardt, W., Marschner, N., Jaenicke, M., Fleitz, A., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Schirmacher, P., Sebastian, M., Thomas, M., 2017. Weiterlesen